A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Sponsored by Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Enrolling at this location
Emory University
Atlanta, Georgia
I'm interestedThis study also enrolls at 60 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.